Volume 19, Number 8—August 2013
Research
Comparison of 2 Assays for Diagnosing Rotavirus and Evaluating Vaccine Effectiveness in Children with Gastroenteritis
Table 2
Comparison of laboratory results in a study of the use of diagnostic assays for rotavirus in children with AGE, 3 New Vaccine Surveillance Network sites (USA), October 2008–October 2009*
Laboratory result | Children with AGE |
Healthy controls |
|||||
---|---|---|---|---|---|---|---|
Rotavirus EIA+, n = 158 | Rotavirus EIA–, n = 490 | p value† | All, n = 500 | p value‡ | p value§ | ||
Virus detected by qRT-PCR |
157 (99) |
65 (13) |
<0.001 |
24 (5) |
<0.001 |
<0.001 |
|
Of those with virus detected | |||||||
Median Ct value (range) | 18 (11–40) | 36 (23–45) | <0.001 | 32 (21–44) | <0.001 | 0.02 | |
G and P type determined | 155 (99) | 8 (12) | <0.001 | 12 (50) | <0.001 | <0.001 | |
Vaccine strain detected | 1 (1) | 0 | 0.52 | 11 (46) | <0.001 | <0.001 |
*Values are no. (%) except as indicated. AGE, acute gastroenteritis; EIA, enzyme immunoassay; +, positive; −, negative; qRT-PCR, semiquantitative reverse transcription PCR; Ct, cycle threshold.
†Children with specimens that are EIA+ vs. EIA− for rotavirus.
‡Children with specimens EIA+ for rotavirus vs. healthy children.
§Children with specimens EIA− for rotavirus vs. healthy children.